The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Huntington’s disease: Clinical presentation and treatment
Abstract
Huntington's disease (HD) is a devastating inherited neurodegenerative disease characterized primarily by progressive motor, cognitive, and psychiatric symptoms. It is caused by autosomal dominant inheritance of an expanded CAG repeat within the Huntington's gene on chromosome 4. In this chapter, we characterize the typical and variant motor phenotypes of the disease and then proceed to describe the cognitive and psychiatric profile. We then give an overview of a suggested multidisciplinary approach to the management of HD, emphasizing the fact that it is a disease which impacts on entire families rather than affecting individuals in isolation. We then describe the pharmacological and nonpharmacological options available for management of specific symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HD is primarily characterized by progressive motor, cognitive, and psychiatric impairments [51].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [51]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,603
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589
Unified Huntington's disease rating scale: Reliability and consistency
(1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,079
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
Self-citationAndrew, S. E., Paul Goldberg, Y., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-398 · Cited by 1,129
Trinucleotide repeat length instability and age of onset in Huntington's disease
Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-387 · Cited by 1,089
Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70170-x · Cited by 984
Self-citation
Research works printed but not linked: 4
- Harper, P.S., Jones, L., Huntington's disease: genetic and molecular studies. In: Huntington's Disease (Bates, Harper, and Jones, eds.), 3rd edition, Oxford Monographs on Medical Genetics 45. ISBN 978-0-19r-r851060-4.
- Kremer, B. Clinical Neurology of Huntington's Disease. In: Huntington's Disease (Bates, Harper, and Jones, eds.), 3rd edition, Oxford Monographs on Medical Genetics 45. ISBN 978-0-19r-r851060-4.
- Nance, M.A., Westphal, B., Comprehensive Care in Huntington's Disease. In: Huntington's Disease (Bates, Harper, and Jones, eds.), 3rd edition, Oxford Monographs on Medical Genetics 45. ISBN 978-0-19r-r851060-4.
- Tabrizi, S.J., Novak, M.J.U., Craufurd, D. (2011). Huntington disease. BMJ Point of Care; www.pointofcare.bmj.com
Cited by
Choosing an animal model for the study of Huntington's disease
Pouladi, M. A., Morton, A. J., & Hayden, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3570 · Cited by 356
The Role of Microglia and Astrocytes in Huntington’s Disease
Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00258 · Cited by 239
“As the disease progresses, the symptoms that patients present with change and vary between cases (Novak and Tabrizi, 2011).”
BackgroundClinical Features of Huntington’s Disease
Ghosh, R., & Tabrizi, S. J. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-71779-1_1 · Cited by 202
Self-citationThe role of tau in the pathological process and clinical expression of Huntington’s disease
Vuono, R., Winder‐Rhodes, S., de Silva, R., Cisbani, G., Drouin‐Ouellet, J., REGISTRY Investigators of the European Huntington’s Disease Network, Spillantini, M. G., Cicchetti, F., & Barker, R. A. (2015) · Brain · doi:10.1093/brain/awv107 · Cited by 143
“Cognitive impairment appears early in the disease course, often leading to dementia which profoundly impacts on quality of life (Ready et al., 2008; Novak and Tabrizi, 2011).”
Sayed, N. H., Fathy, N., Kortam, M. A., Rabie, M. A., Mohamed, A. F., & Kamel, A. S. E. D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00805-5 · Cited by 143
“Huntington’s disease (HD) is a fatal neurodegenerative disease characterized by striatal degeneration leading to motor, psychiatric, and cognitive impairments for which there is no cure and whose progression cannot be slowed down or reversed [1, 2].”
Background
Metadata
- Authors
- Novak, M. J. U., & Tabrizi, S. J.
- Affiliations
- Wellcome Centre for Human Neuroimaging (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- Venue
- International Review of Neurobiology
- Publisher
- Elsevier
- Published
- 2011
- Volume
- 98
- Pages
- 297-323
- ISSN
- 0074-7742 (ISSN-L)
- OpenAlex
- W1702627033
- Cited by
- 137
- References
- 63
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 10 · 2021: 17 · 2020: 7 · 2019: 11 · 2018: 6 · 2017: 10 · 2016: 6 · 2015: 7 · 2014: 11 · 2013: 12 · 2012: 4
- FWCI
- 8.12
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- International review of neurobiology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Huntington's disease, CAG repeat expansion, HTT gene, motor phenotype, cognitive impairment, psychiatric symptoms, neurodegeneration, multidisciplinary management, pharmacotherapy, non-pharmacological treatment, family impact
- MeSH terms
- Huntingtin Protein, Cognition Disorders, Communication Disorders, Humans, Huntington Disease, Nerve Tissue Proteins, Nuclear Proteins, Psychotic Disorders, Sleep Wake Disorders, Trinucleotide Repeat Expansion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Huntington’s disease: Clinical presentation and treatment. https://app.cochat.ai/papers/10.1016/b978-0-12-381328-2.00013-4
- The paper
- Novak, M. J. U., & Tabrizi, S. J. (2011). Huntington’s disease: Clinical presentation and treatment. International Review of Neurobiology. https://doi.org/10.1016/b978-0-12-381328-2.00013-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.